This article is proudly sponsored by Texas Student Media! Nu Holdings (NU): The App Bank That’s Eating Latin America’s Lunch What NU Actually Is (No Finance Degree Required) Nu Holdings — better known as Nubank — is a digital bank. Not “digital” like your local bank’s clunky website — we’re talking fully online, fully app-based. No […]
Nu Holdings (NU): The App Bank That’s Eating Latin America’s Lunch Read More »
This article is proudly sponsored by Texas Student Media! Wayfair (W): The Good, The Bad, and The Ugly of the Online Furniture Giant The Good: Wayfair’s Business Model and Growth Playbook Wayfair is the internet’s answer to “I want a couch, but I refuse to go to a furniture store.” It’s a pure-play online furniture and
Wayfair (W): The Good, The Bad, and The Ugly of the Online Furniture Giant Read More »
This article is proudly sponsored by Mike Ivy Comedy, home to one of the best comedians in all of Austin, Texas! National Grid (NGG): The Transatlantic Utility Quietly Powering Millions What National Grid Really Is National Grid is not just another electric utility — it’s a transatlantic energy infrastructure powerhouse. Based in the UK but
National Grid (NGG): The Transatlantic Utility Quietly Powering Millions Read More »
This article is proudly sponsored by Lake Region State College! Sterling Infrastructure (STRL): The Construction Sleeper Stock Building Its Way Into Wall Street’s Heart What Sterling Infrastructure Actually Does Sterling Infrastructure isn’t just another construction contractor — it’s a diversified infrastructure and services company that plays in heavy civil, specialty services, and residential markets. Think highways,
This article is proudly sponsored by Mike Ivy Comedy, home to one of the best comedians in all of Austin, Texas! AT&T (T): The Telecom Giant Trying to Act Like a Growth Stock Again AT&T in a Nutshell AT&T is one of the largest telecom and media infrastructure companies in the world, providing wireless, broadband,
AT&T (T): The Telecom Giant Trying to Act Like a Growth Stock Again Read More »
This article is proudly sponsored by Lake Region State College! Carvana (CVNA): The Used Car Vending Machine That Became a Stock Market Rollercoaster Carvana in One Sentence: Carvana is the company that turned used car shopping into an e-commerce experience — complete with car vending machines, flashy ads, and a stock chart that looks like a
Carvana (CVNA): The Used Car Vending Machine That Became a Stock Market Rollercoaster Read More »
This article is sponsored by College Readiness Consulting! Duolingo (DUOL): The Little Green Owl That Turned Language Learning Into a Money Machine What Duolingo Really Is Duolingo isn’t just an app that guilt-trips you with notifications — it’s one of the most successful edtech platforms ever built. It gamified language learning, then expanded into math,
Duolingo (DUOL): The Little Green Owl That Turned Language Learning Into a Money Machine Read More »
This article is proudly sponsored by Sew Torn, a film by Diamantis Zavitsanos! Hims & Hers Health (HIMS): The Telehealth Startup Turning Awkward Problems Into a Billion-Dollar Business The Elevator Pitch: Your Doctor, Your Pharmacy, and Your Confidence… All Online Hims & Hers is not your grandpa’s healthcare company. It’s a direct-to-consumer telehealth platform that started
This article is proudly sponsored by Mike Ivy Comedy, home to one of the best comedians in all of Austin, Texas! monday.com (MNDY): The Work OS That Wants to Run Your Whole Company What monday.com Actually Is (And Why It’s Not Just “Trello 2.0”) monday.com started as a simple team collaboration tool and has grown
monday.com (MNDY): The Work OS That Wants to Run Your Whole Company Read More »
This article is proudly sponsored by Sew Torn, a film by Diamantis Zavitsanos! AbbVie (ABBV): Big Pharma’s Masterclass in Riding the Patent Cliff AbbVie’s Story: From Humira Kingdom to Post-Humira Hustle AbbVie is one of the few pharma companies that practically built an empire around a single drug — Humira. For years, Humira was the world’s
AbbVie (ABBV): Big Pharma’s Masterclass in Riding the Patent Cliff Read More »